title: A newly modified hemoglobin H inclusion test as a secondary screening for α(0)-thalassemia in Southeast Asian populations.
abstract: Screening for α(0)-thalassemia is usually associated with a high false-positive rate, leading to an unnecessary PCR workload for accurate diagnosis. We have developed a modified Hb H inclusion test for use as a secondary screening. This test was performed on young red blood cell enriched fractions using dextran sedimentation. The study was performed in 100 subjects positive on initial screening. Confirmatory tests included Hb analysis and a multiplex PCR assay to identify α(0)-thalassemia deletions. A modified Hb H inclusion test was positive in 31 cases, 30 of whom were α(0)-thalassemia carriers (97%). The remaining case (3.0%) was homozygous for α(+)-thalassemia. The remaining 69 cases with a negative Hb H inclusion test included normal subjects, α(+)-thalassemia carriers and β-thalassemia carriers. Two of them (2/69, 3.0%) were found to be double heterozygotes for β(0)-thalassemia and α(0)-thalassemia. The overall sensitivity and specificity of the modified Hb H inclusion test for screening of α(0)-thalassemia were 94.0 and 99.0%, respectively. Therefore, we recommend the use of this test in combination with Hb analysis to exclude cases with αβ-thalassemia. This should lead to a significant reduction in the number of cases referred for PCR analysis of α(0)-thalassemia by about 50.0%.
authors.affiliation: Center for Research and Development of Medical Diagnostic Laboratories, Khon Kaen, Thailand.
authors.forename: Goonnapa
authors.initials: G
authors.lastname: Fucharoen
authors.forename: Khomsan
authors.initials: K
authors.lastname: Yooyen
authors.forename: Attawut
authors.initials: A
authors.lastname: Chaibunruang
authors.forename: Supan
authors.initials: S
authors.lastname: Fucharoen
mesh_terms: D001210:Asia, Southeastern; D004252:DNA Mutational Analysis; D017353:Gene Deletion; D006447:Hemoglobin H / Q000032:analysis* / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008403:Mass Screening / Q000379:methods; D060885:Multiplex Polymerase Chain Reaction; D009996:Osmotic Fragility; D017085:alpha-Thalassemia / Q000097:blood* / Q000175:diagnosis* / Q000235:genetics; D017086:beta-Thalassemia / Q000097:blood / Q000175:diagnosis / Q000235:genetics
chemical_list: D006447:Hemoglobin H